(Q48687385)

English

Utilization of essential medications by vulnerable older people after a drug benefit cap: importance of mental disorders, chronic pain, and practice setting

scientific article published in June 2001

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/11454120

Utilization of essential medications by vulnerable older people after a drug benefit cap: importance of mental disorders, chronic pain, and practice setting (English)

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/11454120

0 references

Stephen B Soumerai

2

object named as

Soumerai SB

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/11454120

Dennis Ross-Degnan

4

object named as

Ross-Degnan D

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/11454120

author name string

Fortess EE

1

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/11454120

McLaughlin TJ

3

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/11454120

language of work or name

0 references

publication date

1 June 2001

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/11454120

Journal of the American Geriatrics Society

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/11454120

49

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/11454120

6

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/11454120

793-797

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/11454120

Payment restrictions for prescription drugs under Medicaid. Effects on therapy, cost, and equity.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1532-5415.2001.49158.X

21 January 2018

Effects of a limiting Medicaid drug-reimbursement benefits on the use of psychotropic agents and acute mental health services by patients with schizophrenia.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1532-5415.2001.49158.X

21 January 2018

Policy and program analysis using administrative databases

1 reference

https://api.crossref.org/works/10.1046%2FJ.1532-5415.2001.49158.X

21 January 2018

Psychotropic drug use and the risk of hip fracture

1 reference

https://api.crossref.org/works/10.1046%2FJ.1532-5415.2001.49158.X

21 January 2018

Optimising drug treatment for elderly people: the prescribing cascade

1 reference

https://api.crossref.org/works/10.1046%2FJ.1532-5415.2001.49158.X

21 January 2018

The impact of implementing a more restrictive prescription limit on Medicaid recipients. Effects on cost, therapy, and out-of-pocket expenditures

1 reference

https://api.crossref.org/works/10.1046%2FJ.1532-5415.2001.49158.X

21 January 2018

Identifiers

10.1046/J.1532-5415.2001.49158.X

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/11454120

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/11454120

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48687385&oldid=2206813319"